BTOG 2024 Highlights

Join us for an enlightening podcast hosted by VJOncology, featuring a panel of renowned experts sharing the latest advancements in lung cancer research from BTOG 2024.  In the first segment, listeners are offered a deep dive into the early stages of lung cancer as Charles Swanton (Francis Crick Institute, London, UK) examines the correlation between air pollution exposure and cancer development. Following this, Thomas Newsom-Davies (Chelsea and Westminster Hospital NHS Foundation Trust, London, UK) provides insight into some of the exciting progress taking place in TNM staging, systematic staging, and immunotherapy. Mariana Brandao (Institute Jules Bordet, Brussels, Belgium) steers the discussion to the complex task of determining operability in non-small cell lung cancer. She emphasizes the importance of a comprehensive operability assessment, highlighting the challenges associated with the disease's complex heterogeneity, particularly in stage three patients. Winding down the session, Robert Rintau (University of Cambridge & Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK,) weighs in on the implications of increased lung cancer survival rates and the evolving approach to treatment.  The podcast rounds off with reflections from Crispin Hiley (UCL, London, UK) on the HIT-Meso trial from and Sanjay Popat (The Royal Marsden NHS Foundation Trust, London, UK) reflects on the success of BTOG 2024 emphasizing the comprehensive representation of multidisciplinary teams dedicated to managing primary thoracic malignancies. Listen now to gain valuable insights into the rapidly evolving landscape of lung cancer treatment and research.